MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
February 13, 2023

ALPINE: Improved PFS, Fewer Cardiac Complications with Zanubrutinib for CLL

By Cameron Kelsall, MD /alert Contributor 

Treatment with zanubrutinib led to significant improvements in progression-free survival when compared with ibrutinib in a cohort of patients with relapsed or refractory chronic lymphocytic leukemia, according to phase 3 study results published in...

 
ALPINE: Improved PFS, Fewer Cardiac Complications with Zanubrutinib for CLL
February 9, 2023

Apremilast as Add-On Therapy Improves Overall Response in Skin Condition

By Jeff Craven, MD /alert Contributor

Nearly all patients with recalcitrant cutaneous dermatomyositis who used apremilast as an add-on therapy showed a response to treatment after 3 months, according to recent research published in...

Apremilast as Add-On Therapy Improves Overall Response in Skin Condition
January 20, 2023

Platelet-Rich Plasma Improves Terminal Hair Density in Women with Androgenic Alopecia

By Jeff Craven, MD /alert Contributor

Autologous platelet-rich plasma (PRP) appears to help improve terminal hair density, but not hair thickness, in women with androgenetic alopecia, according to a recent...

 
 
Platelet-Rich Plasma Improves Terminal Hair Density in Women with Androgenic Alopecia
January 19, 2023

Serplulimab Plus Chemotherapy Improves OS for Patients with Extensive-Stage SCLC

By Cameron Kelsall, MD /alert Contributor

The addition of serplulimab to chemotherapy significantly improved overall survival outcomes compared to chemotherapy alone in patients with previously untreated extensive-stage small cell lung cancer, according to...

Serplulimab Plus Chemotherapy Improves OS for Patients with Extensive-Stage SCLC
January 18, 2023

Genetic Pathways Influence Response to Immunotherapy in Patients with Melanoma

By Cameron Kelsall, MD /alert Contributor

Genetic variation in IL7 expression may be linked to increased immune-related adverse events in patients receiving immune checkpoint blockade for melanoma, according to research published in...

 
 
Genetic Pathways Influence Response to Immunotherapy in Patients with Melanoma
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

INSIGHT-Why world's first malaria shot won't reach millions of children who need it

By Jennifer Rigby, Natalie Grover and Maggie Fick LONDON/KISUMU, Kenya, July 13 (Reuters) - After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.